312 related articles for article (PubMed ID: 23940046)
1. Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation.
Dudakovic A; Evans JM; Li Y; Middha S; McGee-Lawrence ME; van Wijnen AJ; Westendorf JJ
J Biol Chem; 2013 Oct; 288(40):28783-91. PubMed ID: 23940046
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells.
Dudakovic A; Camilleri ET; Lewallen EA; McGee-Lawrence ME; Riester SM; Kakar S; Montecino M; Stein GS; Ryoo HM; Dietz AB; Westendorf JJ; van Wijnen AJ
J Cell Physiol; 2015 Jan; 230(1):52-62. PubMed ID: 24912092
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
4. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.
McGee-Lawrence ME; McCleary-Wheeler AL; Secreto FJ; Razidlo DF; Zhang M; Stensgard BA; Li X; Stein GS; Lian JB; Westendorf JJ
Bone; 2011 May; 48(5):1117-26. PubMed ID: 21255693
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
Lunke S; Maxwell S; Khurana I; K N H; Okabe J; Al-Hasani K; El-Osta A
Clin Epigenetics; 2021 Mar; 13(1):58. PubMed ID: 33743782
[TBL] [Abstract][Full Text] [Related]
6. Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors.
Schroeder TM; Nair AK; Staggs R; Lamblin AF; Westendorf JJ
BMC Genomics; 2007 Oct; 8():362. PubMed ID: 17925016
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic reprogramming enhances the therapeutic efficacy of osteoblast-derived extracellular vesicles to promote human bone marrow stem cell osteogenic differentiation.
Man K; Brunet MY; Fernandez-Rhodes M; Williams S; Heaney LM; Gethings LA; Federici A; Davies OG; Hoey D; Cox SC
J Extracell Vesicles; 2021 Jul; 10(9):e12118. PubMed ID: 34262674
[TBL] [Abstract][Full Text] [Related]
8. Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.
Huang J; Schriefer AE; Yang W; Cliften PF; Rudnick DA
Epigenetics; 2014 Nov; 9(11):1521-31. PubMed ID: 25482284
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
Richon VM; Sandhoff TW; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Library Screen Identifies Abexinostat as Novel Regulator of Adipocytic and Osteoblastic Differentiation of Human Skeletal (Mesenchymal) Stem Cells.
Ali D; Hamam R; Alfayez M; Kassem M; Aldahmash A; Alajez NM
Stem Cells Transl Med; 2016 Aug; 5(8):1036-47. PubMed ID: 27194745
[TBL] [Abstract][Full Text] [Related]
11. Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.
Barbetti V; Gozzini A; Cheloni G; Marzi I; Fabiani E; Santini V; Dello Sbarba P; Rovida E
Epigenetics; 2013 Feb; 8(2):210-9. PubMed ID: 23321683
[TBL] [Abstract][Full Text] [Related]
12. Suberoylanilide hydroxamic acid (SAHA) and cladribine synergistically induce apoptosis in NK-LGL leukaemia.
Sun X; Hasanali ZS; Chen A; Zhang D; Liu X; Wang HG; Feith DJ; Loughran TP; Xu K
Br J Haematol; 2015 Feb; 168(3):371-83. PubMed ID: 25284154
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.
Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H
Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120
[TBL] [Abstract][Full Text] [Related]
14. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1.
Yang PM; Lin PJ; Chen CC
Epigenetics; 2012 Apr; 7(4):390-9. PubMed ID: 22419072
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic treatment remodel genome-wide histone H4 hyper-acetylation patterns and affect signaling pathways in acute promyelocytic leukemia cells.
Valiulienė G; Vitkevičienė A; Navakauskienė R
Eur J Pharmacol; 2020 Dec; 889():173641. PubMed ID: 33045196
[TBL] [Abstract][Full Text] [Related]
16. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
[TBL] [Abstract][Full Text] [Related]
17. Histone acetylation together with DNA demethylation empowers higher plasticity in adipocytes to differentiate into osteoblasts.
Cho YD; Kim BS; Kim WJ; Kim HJ; Baek JH; Woo KM; Seol YJ; Ku Y; Ryoo HM
Gene; 2020 Apr; 733():144274. PubMed ID: 31809844
[TBL] [Abstract][Full Text] [Related]
18. Suberoylanilide hydroxamic acid enhances odontoblast differentiation.
Kwon A; Park HJ; Baek K; Lee HL; Park JC; Woo KM; Ryoo HM; Baek JH
J Dent Res; 2012 May; 91(5):506-12. PubMed ID: 22447851
[TBL] [Abstract][Full Text] [Related]
19. Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells.
Makarević J; Tawanaie N; Juengel E; Reiter M; Mani J; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
J Cell Mol Med; 2014 Jul; 18(7):1460-6. PubMed ID: 24779401
[TBL] [Abstract][Full Text] [Related]
20. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
Ammanamanchi S; Brattain MG
J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
